Press "Enter" to skip to content

FDA warns StemGenex Biologic Laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk

FDA warns StemGenex Biologic Laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm625727.htm

Also Read:   FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic

Be First to Comment

Leave a Reply

Your email address will not be published.